诚纳英才 | 香港中文大学（深圳）医学院招聘临床科室学科带头人
The CUHK-Shenzhen School of Medicine and its affiliated hospitals were born out of an agreement inked by the Shenzhen Municipal People's Government, The Chinese University of Hong Kong and The Chinese University of Hong Kong, Shenzhen in January 2019. At present, Shenzhen is undertaking the historical missions of spearheading the development of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) as a Pilot Demonstration Area of a Special Economic Zone. Against this backdrop of growing opportunities, the establishment of CUHK-Shenzhen MEDICINE is expected to deepen the cooperation between Shenzhen and Hong Kong, upgrade Shenzhen's healthcare services, catalyze GBA’s medical and health care industries, and ultimately fulfill the "Healthy China" national strategy.
Four Bay Areas in the World
Distribution of Colleges and Universities
◈
Population：13.44 million
◈
> 95% of the population：immigrants
◈
USD 425.7 billion GDP in 2020, one of the highest GDP Growth Rates (3.1%) among the major cities in China
◈
4.9% of GDP invested in R&D
◈
300 Fortune 500 invest in Shenzhen
◈
Home to China leading corporations in the Fortune 500, e.g. Huawei, Tencent, and Ping An Insurance
◈
Nurturing emerging giant enterprises of global impact, e.g. BYD Auto, BGI Genomics, DJI-Innovation
◈
An international University taught in English
◈
Curriculum setting based on medical education system of CUHK
◈
CUHK MED (2022) QS world ranking #29
Orientation
Based in Shenzhen and the Greater Bay Area, we are building a world-class medical school integrating three major functions:
◈
high-level medical talent training and recruitment;
◈
advancing comprehensive clinical services;
◈
developing innovative medical research.
Characteristics
◈
International medical education and academic health system;
◈
Implementing innovative future medical education, research, and clinical care;
◈
Rooted in China: medical/teaching/research system and industry/research/partnership system.
MED Campus
Construction Area：550,000m2
Students 6000+
Budget：5.5 billion RMB
Due Time：by the end of 2025
CUHK-Shenzhen Medical Centre
Construction Area：590,000m2
3000 beds
Budget：5.13 billion RMB
Ready to operate in 2025
Admission Plan
The School of Medicine admits undergraduate students into five major programs: Clinical Medicine, Bioinformatics, Biomedical Engineering, Pharmaceutical Science and Biomedical Science. The School is also open for postgraduate admission in the MPhil-PhD program in Biological Sciences. Clinical Medicine, the School's first undergraduate programme, has commenced its first enrolment in 2021, with public health, nursing and traditional Chinese medicine programmes to be offered in phases, and eventually an annual intake of over 6,000 students.
Faculty
50+ Biomedical faculty & 150+ Clinical Medicine Faculty
◈
3 Nobel Prize Winners
◈
1 Foreign Fellows
◈
6 Presidential Chair Professors
◈
70% Senior Professional Title
◈
14+ International Ajunct Professors
◈
100% Doctoral Degree/Have teaching or research experience in world-class universities
◈
34+ National, Provincial, Municipal High-level Talent Projects Selectees
◈
75% Oversea Teaching or Learning Experience
National Research Institute
◈ 3 Nobel Laureate Research Institutes:
Kobilka Institute of Innovative Drug Discovery, Warshl Institute for Computational Biology, Ciechanover Institute of Precision and Regenerative Medicine
◈ Medical cross discipline research institute:
Shenzhen Research Institute of Big Data（Medical Big Data Research Institute）, Shenzhen Institute of Artificial Intelligence and Robotics for Society
◈ Labs & Centers:
The Key Laboratories of Universities in Guangdong Province, Shenzhen key laboratory of steroid drug discovery and development, National-local Joint Engineering Laboratory of Robotics and Intelligent, Futian Biomedical Innovation Research and Development Center, Kobilka Cryo-Electron Microscopy Center, Shenzhen Key Laboratory of Big Data and Artificial Intelligence
Research Topics and Programs
◈ MED Research Priorities:
Cancer Sciences, Brain and Mental Health, Heart and Lung Sciences, Transplantation Sciences, Artificial Intelligence Medicine and Robotics, Public/Population and Health Policy, Traumatology and Intensive Care
◈ Themes:
Cancer Biology, Neurosciences, Stem Cells and Regenerative Medicine, Immunology and Microbiology, Value-based Medicine and Health Technology Assessment, Artificial Intelligence in Healthcare
◈ Platforms:
Biomedical Sciences and Bioinformatics, Data Sciences and Health Informatics, Medical Imaging, Drug and Therapeutics, Computational Biology, Medical Simulation, Hospitals and Industries Partnership
Health System Based Medical Education and Research Innovation
With the support of the government, we integrate medicine with engineering, science and economics, coordinating the development with enterprises on knowledge translation in an industry-university-research model.
International & Local Partnership
◈ International Partnership:
NY Mount Sinai International
University Health Network
Duke-NUS Medical School
◈ Affiliated hospital:
◈ Teaching hospital:
◈
Anesthesiology, Pain & Intensive Care Medicine
◈
Cardiovascular Sciences
◈
Clinical Epidemiology & Population Health
◈
Emergency Medicine & Traumatology
◈
Laboratory Medicine & Pathology
◈
Medical Imaging & Biophysics
◈
Medicine
◈
Neurosciences
◈
Oncology
◈
Ophthalmology & Vision Sciences
◈
Paediatrics
◈
Psychiatry & Behavioral Sciences
◈
Surgery
◈
Women Health & Reproductive Medicine
Salary
Competitive salary package as tenure track Professor.
Subsidy
RMB 2,690,000 to 4,410,000 yuan talent subsidy from governments and the University (upon application), University Benefits.
Research
World-class research equipment, research team and different source of research fund;
Housing
On-campus staff residential apartments or government-support housing;
Others
Children’s education support (affiliated kindergarten, primary school and junior middle school), assist spouse in employment, and provide supplementary commercial insurance.
More information can be found:
https://med.cuhk.edu.cn/en
or contact:
talent4clinical@cuhk.edu.cn
为抢抓粤港澳大湾区和深圳先行示范区“双区”建设重大历史机遇，落实健康中国国家战略的总体要求，深化深港合作内涵，提升深圳医疗卫生服务水平，促进大湾区医疗健康产业发展，深圳市人民政府、香港中文大学、香港中文大学（深圳）于2019年1月正式签订协议共同建设香港中文大学（深圳）医学院及其附属医院。
世界四大湾区的高等教育（高校分布）
◈
人口数量：1344万
◈
>95%人口数量：移民
◈
2020年GDP4257亿美金, 为中国主要城市中GDP增长率最高(3.1%)的城市之一
◈
4.9%研发投入占GDP占比
◈
300家世界500强企业投资在深圳
◈
世界500强中的中国领先企业所在地，如华为、腾讯、平安保险等
◈
培育了具有全球影响力的新兴大型企业，如比亚迪、华大基因、大疆等
◈
一所国际化的医学院，全英文教学
◈
基于香港中文大学医学教育系统的课程设置
◈
香港中文大学医学院在2022年QS世界大学排名全球第29位
办学定位
立足深圳和大湾区，致力建成具备高端医学人才培养、先进医疗服务和创新医学研究三大功能的面向未来的国际化医学院。
办学特色
1.国际化的办学模式
2.面向未来的新医科建设
3.植根本土的医教研体系和产学研体系
医学院主校区
建筑面积: 约55万平方米
计划在校生规模 > 6000
交付时间: 2025年底整体竣工交付
香港中文大学（深圳）医院
建筑面积: 约59万平方米
床位：3000
预算：51.33亿元
交付时间: 2025年6月整体竣工交付
招生计划
目前，医学院已开设五个本科专业：临床医学、生物信息学、生物医学工程、药学和生物科学，两个研究生项目：生物信息学硕士项目（授课型）、生物科学硕博项目（研究型），临床医学本科专业于2021年招收首届新生。未来，医学院将分阶段开设药学院、公共卫生学院、护理学院、中华医学院等，最终计划在校生总规模超过6000人。
师资力量
科研平台
3个诺贝尔奖研究院：
科比尔卡创新药物开发研究院、瓦谢尔计算生物研究院、切哈诺沃精准和再生医学研究院
医学交叉学科研究机构：
深圳市大数据研究院（医学大数据研究院）、深圳市人工智能与机器人研究院
实验室与实验中心：
广东省普通高校生命与健康重点实验室、深圳市甾体类药物研发重点实验室、机器人与智能制造国家与地方联合工程实验室、福田生物医药创新研发中心、科比尔卡冷冻电子显微镜中心、大数据和人工智能重点实验室
学科规划
医学院重点学科建设：
癌症、大脑与心理、心肺科学、移植科学、人工智能医学、公共卫生与医疗政策、重症医学
学科：
癌症生物学、神经科学、干细胞和再生医学、免疫与微生物学、价值医学和医疗科技评估、人工智能医学
平台：
生物医学和生物信息学、数据科学和医疗信息学、医学影像、药物、计算生物学、模拟医学、医院与产业合作
基于卫生系统的医学教育与科研创新
在政府的支持下，医工、医理结合，大学与附属医院协同发展，注重联合企业推动产学研转化。
合作伙伴
国际伙伴
美国
西奈山国际
加拿大
大学健康网络
杜克-新加坡
国立大学医学院
附属医院
教学医院
◉
麻醉、围手术期和重症监护科
◉
心血管科学（心内、心外、心脏影像、血管外科等）
◉
临床流行病学和人口健康
◉
急诊创伤
◉
检验和病理学
◉
医学影像学
◉
内科（消化内科、内分泌科、血液内科、呼吸内科、传染病、微生物学等）
◉
神经科学（神经内科、神经外科、脊柱神经、神经介入等）
◉
肿瘤学
◉
眼科和视觉科学
◉
儿科
◉
精神病学与行为科学
◉
外科（普外科、泌尿外科、肝胆外科、⻣科和运动医学、耳鼻喉头颈外科等）
◉
女性健康与生殖医学（妇产科、生殖医学科等）
以上职位的工作地点均在香港中文大学（深圳）医学院及其附属医院。
职位薪酬
国际一流大学教职体系，丰厚的年薪 （与香港中文大学相当）。
人才补贴
各级政府、学校人才补贴269-441万元 （需满足申请条件）。
配套支持
（1）科研支持：一流的办公条件、实验环境和设备支持，根据科研工作需求配备科研团队和行政秘书等，提供充裕的博士生和博士后指标；
（2）安居支持：提供校内教师公寓和政府安居房；
（3）生活配套：子女入学（附属幼儿园、小学、初中），协助解决配偶就业，除“五险一金“外，提供补充商业保险。
招聘邮箱：talent4clinical@cuhk.edu.cn
更多基础医学、行政职能岗位信息请关注学院网站招聘页面：
https://med.cuhk.edu.cn/en/taxonomy/term/171